Molecular signatures of antibody responses derived from a systems biology study of five human vaccines

Nature Immunology

Volumn 15, Issue 2, 2014, Pages 195-204

  Li, Shuzhao ^a   Rouphael, Nadine ^a   Duraisingham, Sai ^a   Romero Steiner, Sandra ^b   Presnell, Scott ^c,d   Davis, Carl ^a,e   Schmidt, Daniel S ^b   Johnson, Scott E ^b   Milton, Andrea ^b   Rajam, Gowrisankar ^b   Kasturi, Sudhir ^a   Carlone, George M ^b   Quinn, Charlie ^c,d   Chaussabel, Damien ^c,d   Palucka, A Karolina ^d   Mulligan, Mark J ^a,e   Ahmed, Rafi ^a,e   Stephens, David S ^a,e   Nakaya, Helder I ^a,e   Pulendran, Bali ^a,e  

^a EMORY UNIVERSITY   (United States)

^b National Center for Immunizations and Respiratory Diseases   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

^d BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; INACTIVATED VACCINE; INFLUENZA VACCINE; POLYSACCHARIDE VACCINE; TRANSCRIPTOME; YELLOW FEVER VACCINE; ANTIBODY; MENINGOCOCCUS VACCINE; PROTEIN; VACCINE;

ADAPTIVE IMMUNITY; ADULT; ANTIBODY RESPONSE; ARTICLE; CONJUGATE; CONTROLLED STUDY; DATA BASE; HUMAN; HUMAN EXPERIMENT; IMMUNITY; IMMUNOGENICITY; INFLUENZA VACCINATION; INFLUENZA VIRUS; INNATE IMMUNITY; MOLECULAR BIOLOGY; NEISSERIA MENINGITIDIS; NORMAL HUMAN; PRIORITY JOURNAL; SYSTEMS BIOLOGY; TRANSCRIPTION INITIATION; VACCINATION; YELLOW FEVER FLAVIVIRUS; YOUNG ADULT; ANTIBODY TITER; BLOOD; HUMAN CELL; IMMUNE RESPONSE; MENINGOCOCCOSIS; MIDDLE AGED; MOLECULAR MODEL; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; SINGLE DRUG DOSE; TRANSCRIPTOMICS;

ANTIBODY; BLOOD; DATABASE; DOSE-RESPONSE RELATIONSHIP; IMMUNITY; INFLUENZA; POLYSACCHARIDE; PROTEIN; VACCINE; VIRUS; YELLOW FEVER;

ADOLESCENT; ADULT; ANTIBODY FORMATION; COMPUTER SIMULATION; FEMALE; HUMANS; IMMUNITY, ACTIVE; IMMUNOGLOBULINS; INFLUENZA VACCINES; MALE; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; MIDDLE AGED; NEISSERIA MENINGITIDIS; SYSTEMS BIOLOGY; TRANSCRIPTOME; VACCINES, CONJUGATE; YELLOW FEVER VACCINE; YOUNG ADULT;

EID: 84896345445     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2789     Document Type: Article

References (66)

1. Pulendran, B. Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology. Nat. Rev. Immunol. 9, 741-747 (2009).
2. Pulendran, B., Li, S. & Nakaya, H.I. Systems vaccinology. Immunity 33, 516-529 (2010).
3. Nakaya, H.I. & Pulendran, B. Systems vaccinology: its promise and challenge for HIV vaccine development. Curr. Opin. HIV AIDS 7, 24 (2012).
4. Querec, T.D. et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10, 116-125 (2008).
5. Gaucher, D. et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205, 3119-3131 (2008).
6. Nakaya, H.I. et al. Systems biology of vaccination for seasonal influenza in humans. Nat. Immunol. 12, 786-795 (2011).
7. Vahey, M.T. et al. Expression of genes associated with immunoproteasome processing of major histocompatibility complex peptides is indicative of protection with adjuvanted RTS,S malaria vaccine. J. Infect. Dis. 201, 580-589 (2010).
8. Bucasas, K.L. et al. Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans. J. Infect. Dis. 203, 921-929 (2011).
9. Zak, D.E. et al. Merck Ad5/HIV induces broad innate immune activation that predicts CD8+ T-cell responses but is attenuated by preexisting Ad5 immunity. Proc. Natl. Acad. Sci. USA 109, E3503-E3512 (2012).
10. Obermoser, G. et al. Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity 38, 831-844 (2013).
11. Furman, D. et al. Apoptosis and other immune biomarkers predict influenza vaccine responsiveness. Mol. Syst. Biol. 9, 659 (2013).
12. Oberg, A.L., Kennedy, R.B., Li, P., Ovsyannikova, I.G. & Poland, G.A. Systems biology approaches to new vaccine development. Curr. Opin. Immunol. 23, 436-443 (2011).
13. Trautmann, L. & Sekaly, R. Solving vaccine mysteries: a systems biology perspective. Nat. Immunol. 12, 729 (2011).
14. Querec, T. et al. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J. Exp. Med. 203, 413-424 (2006).
15. Geeraedts, F. et al. Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling. PLoS Pathog. 4, e1000138 (2008).
16. Koyama, S. et al. Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes. Sci. Transl. Med. 2, 25ra24 (2010).
17. Rouphael, N.G. & Stephens, D.S. Neisseria meningitidis: biology, microbiology, and epidemiology. Methods Mol. Biol. 799, 1-20 (2012).
18. Goldschneider, I., Gotschlich, E.C. & Artenstein, M.S. Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med. 129, 1307-1326 (1969).
19. Käyhty, H., Karanko, V., Peltola, H., Sarna, S. & Makela, P.H. Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children. J. Infect. Dis. 142, 861-868 (1980).
20. Jokhdar, H. et al. Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A/C polysaccharide vaccination in Saudi Arabia. Clin. Diagn. Lab. Immunol. 11, 83-88 (2004).
21. Findlow, H. et al. Immunoglobulin G subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate vaccine. Clin. Vaccine Immunol. 13, 507-510 (2006).
22. Borrow, R., Balmer, P. & Miller, E. Meningococcal surrogates of protection-serum bactericidal antibody activity. Vaccine 23, 2222-2227 (2005).
23. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545-15550 (2005).
24. Cerami, E., Demir, E., Schultz, N., Taylor, B.S. & Sander, C. Automated network analysis identifies core pathways in glioblastoma. PLoS ONE 5, e8918 (2010).
25. Nibbe, R.K., Koyuturk, M. & Chance, M.R. An integrative-omics approach to identify functional sub-networks in human colorectal cancer. PLOS Comput. Biol. 6, e1000639 (2010).
26. Khatri, P., Sirota, M. & Butte, A.J. Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput. Biol. 8, e1002375 (2012).
27. Li, S., Nakaya, H.I., Kazmin, D.A., Oh, J.Z. & Pulendran, B. Systems biological approaches to measure and understand vaccine immunity in humans. Semin. Immunol. 25, 209-218 (2013).
28. Schaefer, C.F. et al. PID: the Pathway Interaction Database. Nucleic Acids Res. 37, D674-D679 (2009).
29. Lau, E. & Ronai, Z.A. ATF2-at the crossroad of nuclear and cytosolic functions. J. Cell Sci. 125, 2815-2824 (2012).
30. Chaveroux, C. et al. Identification of a novel amino acid response pathway triggering ATF2 phosphorylation in mammals. Mol. Cell Biol. 29, 6515-6526 (2009).
31. Ravindran, R. et al. Vaccine activation of the nutrient sensor GCN2 in dendritic cells enhances antigen presentation. Science (in the press).
32. Haining, W.N. & Pulendran, B. Identifying gnostic predictors of the vaccine response. Curr. Opin. Immunol. 24, 332-336 (2012).
33. Chaussabel, D., Pascual, V. & Banchereau, J. Assessing the human immune system through blood transcriptomics. BMC Biol. 8, 84 (2010).
34. Fraser, I.D.C. & Germain, R.N. Navigating the network: signaling cross-talk in hematopoietic cells. Nat. Immunol. 10, 327-331 (2009).
35. Friedman, N. Inferring cellular networks using probabilistic graphical models. Science 303, 799-805 (2004).
36. Segal, E. et al. Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data. Nat. Genet. 34, 166-176 (2003).
37. Basso, K. et al. Reverse engineering of regulatory networks in human B cells. Nat. Genet. 37, 382-390 (2005).
38. Lee, I. et al. A single gene network accurately predicts phenotypic effects of gene perturbation in Caenorhabditis elegans. Nat. Genet. 40, 181-188 (2008).
39. Chaussabel, D. et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 29, 150-164 (2008).
40. Margolin, A.A. et al. ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinformatics 7 (suppl. 1), S7 (2006).
41. Lefebvre, C. et al. A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers. Mol. Syst. Biol. 6, 377 (2010).
42. Lefebvre, C., Rieckhof, G. & Califano, A. Reverse-engineering human regulatory networks. Wiley Interdiscip. Rev. Syst. Biol. Med. 4, 311-325 (2012).
43. Sales, G. & Romualdi, C. Parmigene-a parallel R package for mutual information estimation and gene network reconstruction. Bioinformatics 27, 1876-1877 (2011).
44. Chuang, H.Y., Lee, E., Liu, Y.T., Lee, D. & Ideker, T. Network-based classification of breast cancer metastasis. Mol. Syst. Biol. 3, 140 (2007).
45. Fredlund, E., Ringner, M., Maris, J.M. & Pahlman, S. High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma. Proc. Natl. Acad. Sci. USA 105, 14094-14099 (2008).
46. Vitour, D. et al. Polo-like kinase 1 (PLK1) regulates interferon (IFN) induction by MAVS. J. Biol. Chem. 284, 21797-21809 (2009).
47. Zhang, W. et al. The scaffold protein TANK/I-TRAF inhibits NF-κB activation by recruiting polo-like kinase 1. Mol. Biol. Cell 21, 2500-2513 (2010).
48. Zughaier, S.M. Neisseria meningitidis capsular polysaccharides induce inflammatory responses via TLR2 and TLR4-MD-2. J. Leukoc. Biol. 89, 469-480 (2011).
49. Klein, S.L. & Poland, G.A. Personalized vaccinology: one size and dose might not fit both sexes. Vaccine 31, 2599-2600 (2013).
50. Nakaya, H.I., Li, S.Z. & Pulendran, B. Systems vaccinology: learning to compute the behavior of vaccine induced immunity. Wiley Interdiscip. Rev. Syst. Biol. Med. 4, 193-205 (2012).
51. Avci, F.Y., Li, X.M., Tsuji, M. & Kasper, D.L. A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design. Nat. Med. 17, 1602-1609 (2011).
52. Holder, P.K. et al. Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992. Clin. Diagn. Lab. Immunol. 2, 132-137 (1995).
53. Gheesling, L.L. et al. Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J. Clin. Microbiol. 32, 1475-1482 (1994).
54. van Gageldonk, P.G., van Schaijk, F.G., van der Klis, F.R. & Berbers, G.A. Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus. J. Immunol. Methods 335, 79-89 (2008).
55. Maslanka, S.E. et al. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group. Clin. Diagn. Lab. Immunol. 4, 156-167 (1997).
56. Poolman, J.T. et al. Measurement of functional anti-meningococcal serogroup a activity using strain 3125 as the target strain for serum bactericidal assay. Clin. Vaccine Immunol. 18, 1108-1117 (2011).
57. Wrammert, J. et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453, 667-671 (2008).
58. Moreno, R.L. et al. A murine model for the study of immune memory in response to pneumococcal conjugate vaccination. Vaccine 22, 3069-3079 (2004).
59. Cerami, E.G. et al. Pathway Commons, a web resource for biological pathway data. Nucleic Acids Res. 39, D685-D690 (2011).
60. Keshava Prasad, T.S. et al. Human Protein Reference Database-2009 update. Nucleic Acids Res. 37, D767-D772 (2009).
61. Breitkreutz, B.J. et al. The BioGRID Interaction Database: 2008 update. Nucleic Acids Res. 36, D637-D640 (2008).
62. Aranda, B. et al. The IntAct molecular interaction database in 2010. Nucleic Acids Res. 38, D525-D531 (2010).
63. Ceol, A. et al. MINT, the molecular interaction database: 2009 update. Nucleic Acids Res. 38, D532-D539 (2010).
64. Matthews, L. et al. Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res. 37, D619-D622 (2009).
65. Romero, P. et al. Computational prediction of human metabolic pathways from the complete human genome. Genome Biol. 6, R2 (2005).
66. Huang, D.W., Sherman, B.T. & Lempicki, R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57 (2009).